ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® 2024 Insights: "Results of Preliminary Safety & Efficacy of Belantamab Mafodotin and Elotuzumab in R/R MM"
By
ecancer
FEATURING
Natalia Neparidze
By
ecancer
FEATURING
Natalia Neparidze
Login to view comments.
Click here to Login
